Wave Life Sciences Ltd. (WVE)

Name: Wave Life Sciences Ltd. (WVE) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Wave Life Sciences Ltd. (WVE)

Stock Card

$5.23

$-0.02 (-0.38%)

As on 26-Aug-2026 16:23EDT

Market cap

$1,042 Mln

Revenue (TTM)

$65 Mln

P/E Ratio

P/B Ratio

2.3

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

Wave Life Sciences (WVE) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 5.18 High: 5.30

52 Week Range

Low: 5.01 High: 21.73

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.7 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-10.1
Debt to Equity

0
Book Value

$--
EPS

$-1.1
Face value

--
Shares outstanding

197,048,175

10 Years Aggregate

CFO

$-695.78 Mln

EBITDA

$-1,044.08 Mln

Net Profit

$-999.51 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Wave Life Sciences (WVE)	-69.2	-10.0	-18.0	-47.4	3.3	-2.5	-14.2
BSE Sensex^*	-8.7	1.6	1.7	-4.3	6.0	6.7	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 26-Aug-2026 | *As on 27-Aug-2026 | #As on 26-Oct-2023

Company	2025	2023	2022	2021	2020	2019
Wave Life Sciences (WVE)	37.4	-27.9	122.9	-60.1	-1.8	-80.9
S&P Small-Cap 600	4.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Wave Life Sciences (WVE)

Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry... innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts. Read more

President, CEO & Director

Dr. Paul B. Bolno M.B.A., M.D.
President, CEO & Director

Dr. Paul B. Bolno M.B.A., M.D.
Headquarters

Cambridge, MA
Website

https://wavelifesciences.com

FAQs for Wave Life Sciences (WVE)

What is the current share price of Wave Life Sciences Ltd (WVE) Today?

The share price of Wave Life Sciences Ltd (WVE) is $5.23 (NASDAQ) as of 26-Aug-2026 16:23 EDT. Wave Life Sciences Ltd (WVE) has given a return of 3.33% in the last 3 years.

What is the current PB & PE ratio of Wave Life Sciences Ltd (WVE)?

Since, TTM earnings of Wave Life Sciences Ltd (WVE) is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-14.98	5.82
2024	-21.97	10.17
2023	-9.63	13.97
2022	-4.07	-14.59
2021	-1.47	5.53

What is the 52 Week High and Low of Wave Life Sciences Ltd (WVE)?

The 52-week high and low of Wave Life Sciences Ltd (WVE) are Rs 21.73 and Rs 5.01 as of 27-Aug-2026.

What is the market cap of Wave Life Sciences Ltd (WVE)?

Wave Life Sciences Ltd (WVE) has a market capitalisation of $ 1,042 Mln as on 21-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Wave Life Sciences Ltd (WVE)?

Before investing in Wave Life Sciences Ltd (WVE), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.